PODD — Insulet Corporation
PODD dilution and offerings
- Float: 70.0M shares
🔔 Alert me if PODD files an offering or S-3
$153.61+2.63%
Last close: · regular session
Last 60 sessions
Float: 70.0M shares. Latest SEC filing: SCHEDULE 13G/A on Aug 6, 2026. PODD closed at $153.61 (+2.63%) on Nov 2, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for PODD in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 5,400
- Website: https://www.insulet.com
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Latest SEC filings for PODD
Latest PODD news
- Insulet Q3 2026 Earnings Preview Read article
- Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth Read article
- Here's Why Insulet (PODD) is a Strong Growth Stock Read article
- Insulet Announces Omnipod Discover Now Available in U.S. Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.